FDA Approves Pill to Treat MS Relapses
Links shared publicly online about this topic
FDA Approves Breakthrough Pill to Treat (MS) - Patient Power
patientpower.info — “The first-ever oral therapy to treat relapsing-remitting multiple sclerosis has been approved by the FDA. University of Washington neurologist and MS specialist, Dr. Sylvia Lucas, explains what it means and gives guidance for patients.” View full resource at patientpower.info
Most Recently Shared on September 24, 2010 at 8:14 pm By:
Want to know more about pill approved by FDA to treat MS? UW's Dr. Sylvia Lucas talks @patientpower http://ow.ly/2Jzoo #multiplesclerosis
FDA Approves Breakthrough Pill to Treat Multiple Sclerosis - Patient Power
patientpower.info — “The first-ever oral therapy to treat relapsing-remitting multiple sclerosis has been approved by the FDA. University of Washington neurologist and MS specialist, Dr. Sylvia Lucas, explains what it means and gives guidance for patients.” View full resource at patientpower.info
Most Recently Shared on September 24, 2010 at 8:22 pm By:
Our Breaking News interview with Dr. Sylvia Lucas: FDA Approves Breakthrough Pill to Treat #MS #Gilenya - Patient Power http://t.co/lco3wo2
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 11:11 pm By:
Pill to Treat Multiple Sclerosis Receives Approval of F.D.A. http://nyti.ms/adAQS4
F.D.A. Approves Novartis's Gilenya, a Treatment for M.S. - NYTimes.com
nytimes.com — “Agency backing had largely been expected after a unanimous recommendation by an advisory panel in June for the treatment of relapsing multiple sclerosis.” View full resource at nytimes.com
Most Recently Shared on September 22, 2010 at 10:54 pm By:
Pill to Treat Multiple Sclerosis Receives Approval of F.D.A.: Agency backing had largely been expected after a una... http://bit.ly/9rjZeO
FDA Approves 1st Oral Drug for MS Relapses - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration on Wednesday approved the first oral drug to treat relapses of multiple sclerosis, the nervous system disorder that has tr” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 5:12 pm By:
Drugs and Devices OW OW Health
FDA Approves 1st Oral Drug for MS Relapses: WEDNESDAY, Sept. 22 -- The U.S. Food and Drug Administration on W... http://bit.ly/9DDXUt #drug
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression
drugs.com — “Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 11:41 pm By:
FDA Approves Gilenya, A Novel First-Line Multiple Sclerosis Treatment - http://bit.ly/ddfXwp
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significantly Reduce Relapses And Delay Disability Progression
drugs.com — “Gilenya (fingolimod) is used to treat relapsing forms of multiple sclerosis. Includes Gilenya side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 11:17 pm By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval For Gilenya, A Novel First-Line Multiple Sclerosis Treatment Shown To Significant... http://bit.ly/dp1Zza #drug
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
fda.gov — “The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.” View full resource at fda.gov
Most Recently Shared on January 22, 2010 at 9:13 pm By:
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis http://bit.ly/6aiiOF
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
drugs.com — “Ampyra (dalfampridine) is used to to improve walking in patients with multiple sclerosis. Includes Ampyra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 22, 2010 at 10:58 pm By:
FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis - http://bit.ly/8TmU1y
FDA Approves Ampyra To Improve Walking In Adults With Multiple Sclerosis
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated wit” View full resource at medicalnewstoday.com
Most Recently Shared on January 23, 2010 at 9:06 pm By:
MNT Clinical Trials Health News
FDA Approves Ampyra To Improve Walking In Adults With Multiple Sclerosis http://mnt.to/3wHN #clinicaltrials
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
thirdage.com — “Multiple Sclerosis drug Novartis has been approved by The Food and Drug Administration. Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has” View full resource at thirdage.com
Most Recently Shared on September 22, 2010 at 9:32 pm By:
Multiple sclerosis drug Novartis gains FDA approval! http://dld.bz/wDdx
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
thirdage.com — “Multiple Sclerosis drug Novartis has been approved by The Food and Drug Administration. Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has” View full resource at thirdage.com
Most Recently Shared on September 22, 2010 at 8:07 pm By:
Multiple Sclerosis Drug Novartis Gains FDA Approval: Multiple Sclerosis drug Novartis has been approved by The Foo... http://bit.ly/d2TMIA
FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS
novartis.com — “FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS” View full resource at novartis.com
Most Recently Shared on June 10, 2010 at 11:24 pm By:
Today an FDA advisory committee voted in favor of our investigational therapy for #MS. http://bit.ly/d1K6KF
FDA gives approval for new MS drug - Health - msnbc.com
msnbc.msn.com — “U.S. government health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.” View full resource at msnbc.msn.com
Most Recently Shared on September 22, 2010 at 4:07 pm By:
msnbc.com - Health Health News
FDA gives approval for new MS drug http://bit.ly/bESJjp
FDA approves first-ever pill to treat underlying causes of MS
nydailynews.com — “Debilitating nervous system disorder has traditionally been treated with injectable drugs.” View full resource at nydailynews.com
Most Recently Shared on September 22, 2010 at 3:05 pm By:
FDA approves first-ever pill to treat underlying causes of MS: Debilitating nervous system disorder has traditiona... http://bit.ly/9nmSTL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
UW Medicine News
UWMed is Harborview, UW Med Ctr, UW Med Clinics, School of Medicine, Northwest Hospital & Med Ctr and Airlift Northwest
-
Andrew Schorr
Medical journalist, cancer survivor, patient advocate, founder/owner of PatientPower.info
-
NYTimes Health
Health News from NYTimes.com/Health
Advertisement
